Does METRELEPTIN Cause Product dose omission issue? 88 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Product dose omission issue have been filed in association with METRELEPTIN (Myalept). This represents 7.8% of all adverse event reports for METRELEPTIN.
88
Reports of Product dose omission issue with METRELEPTIN
7.8%
of all METRELEPTIN reports
2
Deaths
22
Hospitalizations
How Dangerous Is Product dose omission issue From METRELEPTIN?
Of the 88 reports, 2 (2.3%) resulted in death, 22 (25.0%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METRELEPTIN. However, 88 reports have been filed with the FAERS database.
What Other Side Effects Does METRELEPTIN Cause?
Therapy cessation (94)
Weight decreased (88)
Blood glucose increased (77)
Drug ineffective (69)
Therapy interrupted (65)
Nausea (57)
Off label use (51)
Blood triglycerides increased (49)
Treatment noncompliance (49)
Weight increased (45)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which METRELEPTIN Alternatives Have Lower Product dose omission issue Risk?
METRELEPTIN vs METRONIDAZOLE
METRELEPTIN vs METRONIDAZOLE\METRONIDAZOLE
METRELEPTIN vs METYRAPONE
METRELEPTIN vs MEXILETINE
METRELEPTIN vs MIANSERIN